Another Paragon offshoot inks reverse merger as Jade takes Aerovate’s place

Paragon Therapeutics, a company that spins out antibody biotechs, has forged a second reverse merger for its portfolio this week. Its autoimmune spinoff Jade Biosciences will take the Nasdaq spot of Aerovate Therapeutics in an ...